Three things to know:
1. The new reimbursement code for Anjeso is C9059. It is set to take effect July 1 for ASCs and hospital outpatient departments.
2. Baudax Bio announced the new pass-through status and commercial launch of Anjeso June 15.
3. Anjeso gained FDA approval earlier in the year, for use alone or in combination with non-steroidal anti-inflammatory drugs.
More articles on ASCs:
The ‘new normal’ for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR ‘made all the more important’ by COVID-19
Indiana orthopedic practice with surgery center to open
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.